US$ 25.44
glp-1 legal team / Ozempic π’ Navigating Updated GLP-1 Regulations
Description
However, up to 89% of participants taking efinopegdutide experienced gastrointestinal adverse events (mostly nausea, vomiting and diarrhoea) relative to 28% taking placebo and 60% taking liraglutide (86)

Research indicates that managing type 2 diabetes involves focusing on a diet rich in high-fiber foods like vegetables, fruits, legumes, and whole grains while limiting the intake of saturated fatty acids

So it's gonna be a minimum of two to three times a week
However, gastrointestinal side effects such as diarrhea (2030%) and nausea with a metallic taste (1020% dropout rate) are common
